Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zerbib

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Alimentary Pharmacology & Therapeutics|November 5, 2005
Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjectsF Zerbib, S Bruley des Varannes, S Roman, et al.
Alimentary Pharmacology & Therapeutics|February 20, 2015
Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapyN J Shaheen, J Adler, S Dedrie, et al.
Alimentary Pharmacology & Therapeutics|May 15, 2009
Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional studyD Laharie, C Asencio, J Asselineau, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 27, 2023
Deep ulcers are associated with increased C-reactive protein in active ulcerative colitisP Rivière, A Le Chevillier, A Rullier, et al.
Neurogastroenterology and Motility|April 4, 2017
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus groupS Roman, C P Gyawali, E Savarino, et al.
Neurogastroenterology and Motility|December 23, 2014
Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatmentJ Tack, F Zerbib, K Blondeau, et al.
The American Journal of Gastroenterology|October 4, 2012
Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a)A M Leroi, L Siproudhis, I Etienney, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 19, 2010
Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: results of trial stimulation in 200 patientsS Gallas, F Michot, J L Faucheron, et al.
Gut|July 1, 1997
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxinC Cuillière, P Ducrotté, F Zerbib, et al.
Neurogastroenterology and Motility|August 2, 2016
Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometryS Roman, R Holloway, J Keller, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|November 5, 2005
Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjectsF Zerbib, S Bruley des Varannes, S Roman, et al.
Alimentary Pharmacology & Therapeutics|February 20, 2015
Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapyN J Shaheen, J Adler, S Dedrie, et al.
Alimentary Pharmacology & Therapeutics|May 15, 2009
Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional studyD Laharie, C Asencio, J Asselineau, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 27, 2023
Deep ulcers are associated with increased C-reactive protein in active ulcerative colitisP Rivière, A Le Chevillier, A Rullier, et al.
Neurogastroenterology and Motility|April 4, 2017
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus groupS Roman, C P Gyawali, E Savarino, et al.
Neurogastroenterology and Motility|December 23, 2014
Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatmentJ Tack, F Zerbib, K Blondeau, et al.
The American Journal of Gastroenterology|October 4, 2012
Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a)A M Leroi, L Siproudhis, I Etienney, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|March 19, 2010
Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: results of trial stimulation in 200 patientsS Gallas, F Michot, J L Faucheron, et al.
Gut|July 1, 1997
Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxinC Cuillière, P Ducrotté, F Zerbib, et al.
Neurogastroenterology and Motility|August 2, 2016
Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometryS Roman, R Holloway, J Keller, et al.
Pageof 8